We have collected information regarding stocks with the highest payout ratio at the moment. The payout ratio in itself isn't a guarantee of good investment but it's an indicator of whether dividends are being paid and how the company chooses to issue them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know and anything around 60 percent is considered high.
1. Mid
142.96% Payout Ratio
MAA, an S&P 500 company, is a real estate investment trust, or REIT, focused on delivering full-cycle and superior investment performance for shareholders through the ownership, management, acquisition, development and redevelopment of quality apartment communities in the Southeast, Southwest, and Mid-Atlantic regions of the United States.
As stated by Morningstar, Inc., the next dividend pay date is on Jan 13, 2021, the estimated forward annual dividend rate is 4.1 and the estimated forward annual dividend yield is 3.41%.
Mid sales growth this year is expected to be 2.3% and 2.8% for next year.
Year-on-year quarterly revenue growth grew by 1.8%, now sitting on 1.67B for the twelve trailing months.
Mid's sales growth for the next quarter is 1.6%. The company's growth estimates for the current quarter and the next is a negative 59.2% and 67.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.39%.
Mid's Stock Top and Bottom Yearly Value
Mid's stock is valued at $120.18 at 19:58 EST, way under its 52-week high of $148.88 and way above its 52-week low of $82.00.
Mid's Moving Average
Mid's worth is below its 50-day moving average of $123.67 and above its 200-day moving average of $118.47.
2. First Trust Enhanced Equity Income Fund
175.38% Payout Ratio
First Trust Enhanced Equity Income Fund is a closed-ended equity mutual fund launched and managed by First Trust Advisors L.
As stated by Morningstar, Inc., the next dividend pay date is on Sep 21, 2020, the estimated forward annual dividend rate is 1.14 and the estimated forward annual dividend yield is 6.69%.
First Trust Enhanced Equity Income Fund sales growth this year is anticipated to be negative 0% and a negative 0% for next year.
Year-on-year quarterly revenue growth declined by 12%, now sitting on 6.6M for the twelve trailing months.
First Trust Enhanced Equity Income Fund's sales growth is a negative 0% for the ongoing quarter and negative 0% for the next. The company's growth estimates for the present quarter and the next is a negative 0% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.1%.
First Trust Enhanced Equity Income Fund's Stock Top and Bottom Yearly Value
First Trust Enhanced Equity Income Fund's stock is valued at $16.88 at 19:58 EST, under its 52-week high of $17.75 and way above its 52-week low of $9.17.
First Trust Enhanced Equity Income Fund's Moving Average
First Trust Enhanced Equity Income Fund's value is above its 50-day moving average of $15.88 and way above its 200-day moving average of $15.22.
3. Blackrock International Real Estate Fund, Inc.
676% Payout Ratio
BlackRock Enhanced International Dividend Trust is a closed ended equity mutual fund launched by BlackRock, Inc.
According to Morningstar, Inc., the next dividend pay date is on Dec 13, 2020, the estimated forward annual dividend rate is 0.41 and the estimated forward annual dividend yield is 6.97%.
BLACKROCK INTERNATIONAL, LTD. Blackrock International Real Estate Fund, Inc. sales growth this year is anticipated to be negative 0% and a negative 0% for next year.
Year-on-year quarterly revenue growth declined by 28%, now sitting on 19.44M for the twelve trailing months.
BLACKROCK INTERNATIONAL, LTD. Blackrock International Real Estate Fund, Inc.'s sales growth is a negative 0% for the current quarter and negative 0% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 0% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 0.78%.
Blackrock International Real Estate Fund, Inc.'s Stock Top and Bottom Yearly Value
BLACKROCK INTERNATIONAL, LTD. Blackrock International Real Estate Fund, Inc.'s stock is valued at $5.79 at 19:58 EST, under its 52-week high of $5.96 and way above its 52-week low of $3.73.
Blackrock International Real Estate Fund, Inc.'s Moving Average
BLACKROCK INTERNATIONAL, LTD. Blackrock International Real Estate Fund, Inc.'s worth is above its 50-day moving average of $5.53 and higher than its 200-day moving average of $5.38.
4. Crane Company
400% Payout Ratio
Crane Co. manufactures and sells engineered industrial products in the United States, Canada, the United Kingdom, Continental Europe, and internationally.
According to Morningstar, Inc., the next dividend pay date is on Nov 26, 2020, the estimated forward annual dividend rate is 1.72 and the estimated forward annual dividend yield is 2.34%.
Crane Company sales growth this year is expected to be negative 10% and 6.1% for next year.
Year-on-year quarterly revenue growth declined by 4.9%, now sitting on 3.05B for the twelve trailing months.
Crane Company's sales growth for the next quarter is a negative 4.9%. The company's growth estimates for the present quarter and the next is a negative 31% and negative -1.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 1.35%.
Crane Company's Stock Top and Bottom Yearly Value
Crane Company's stock is valued at $74.86 at 19:58 EST, way below its 52-week high of $89.54 and way higher than its 52-week low of $36.77.
Crane Company's Moving Average
Crane Company's worth is way above its 50-day moving average of $62.28 and way above its 200-day moving average of $57.94.
5. Corrections Corporation of America
84.62% Payout Ratio
The Company is a diversified government solutions company with the scale and experience needed to solve tough government challenges in flexible, cost-effective ways.
According to Morningstar, Inc., the next dividend pay date is on Mar 30, 2020, the estimated forward annual dividend rate is a negative 0 and the estimated forward annual dividend yield is a negative0%.
Corrections Corporation of America sales growth this year is anticipated to be negative 3.8% and 2.3% for next year.
Year-on-year quarterly revenue growth declined by 7.9%, now sitting on 1.93B for the twelve trailing months.
Corrections Corporation of America's sales growth is a negative 5% for the ongoing quarter and negative 0% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 41.5% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.81%.
Corrections Corporation of America's Stock Top and Bottom Yearly Value
Corrections Corporation of America's stock is valued at $7.65 at 19:58 EST, way below its 52-week high of $17.90 and way above its 52-week low of $5.76.
Corrections Corporation of America's Moving Average
Corrections Corporation of America's worth is way higher than its 50-day moving average of $6.91 and way under its 200-day moving average of $8.89.
Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
